{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-173770","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2026-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.865661+00:00","generated_at":"2026-05-15T04:24:05.852071+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioMarin receives French FDI clearance for Amicus merger; closing expected April 27, 2026","bullets":["French Ministry of Economics and Finance granted FDI clearance for merger with Amicus on April 23, 2026.","Receipt of clearance satisfies final condition to the merger other than closing conditions.","Merger expected to close on April 27, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-173770","json":"https://secwatch.observer/filing/0001193125-26-173770.json","markdown":"https://secwatch.observer/filing/0001193125-26-173770.md","text":"https://secwatch.observer/filing/0001193125-26-173770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/0001193125-26-173770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/d139584d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:24:05.852071+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}